Barclays Maintains Underweight on Copart, Lowers Price Target to $26

Benzinga Newsdesk www.benzinga.com Negative 88.3%

Neg 88.3% Neu 0% Pos 0%

Barclays analyst John Babcock maintains Copart (NASDAQ:CPRT) with a Underweight and lowers the price target from $32 to $26.